Opiant Pharmaceuticals Inc., of Santa Monica, Calif., and Titan Pharmaceuticals Inc., of South San Francisco, are collaborating to develop a product for the prevention of opioid relapse and overdose in individuals with opioid use disorder using Titan's Proneura sustained-release technology.